{
    "name": "ceftolozane/tazobactam",
    "comment": "Rx",
    "other_names": [
        "Zerbaxa"
    ],
    "classes": [
        "Cephalosporins",
        "Other"
    ],
    "source": "https://reference.medscape.com/drug/zerbaxa-ceftolozane-tazobactam-999969",
    "pregnancy": {
        "common": [
            "There are no data available on ceftolozane/tazobactam or its individual components regarding use in pregnant women to assess drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes",
            "Human data: Although available studies with multiple cephalosporins cannot definitively establish absence of risk, published data from prospective cohort studies, case series, and case reports over several decades have not identified an association of cephalosporin use during pregnancy with major birth defects, miscarriage, or other adverse maternal or fetal outcomes"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "There are no data on presence of either drug component in human milk; there are no data on effects of either drug component on breastfed infant, or on milk production",
            "Developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for therapy and any potential adverse effects on breastfed child from therapy or from underlying maternal conditions"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Hypersensitivity to any of the components"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Clinical cure rates lower in patients with baseline CrCl of 30 to ≤50 mL/min when compared with other antibiotics in clinical trials; monitor CrCl at least daily in patients with changing renal function and adjust dosage accordingly",
                "Serious and occasionally fatal hypersensitivity (anaphylactic) reactions reported with beta-lactam antibacterial agents; before initiating therapy make careful inquiry about previous hypersensitivity reactions to other cephalosporins, penicillins, or other beta-lactams; if this product is to be given to a patient with a cephalosporin, penicillin, or other beta-lactam allergies, exercise caution because cross-sensitivity has been established; if an anaphylactic reaction occurs, discontinue drug and institute appropriate therapy",
                "Prescribing antibiotics in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit to the patient and risks the development of drug-resistant bacteria"
            ],
            "specific": [
                {
                    "type": "Clostridium difficile-associated diarrhea",
                    "description": [
                        "As with all antibiotics, Clostridium difficile-associated diarrhea (CDAD) has been reported; may range in severity from mild diarrhea to fatal colitis; treatment with antibacterial agents alters normal flora of colon and may permit overgrowth of C. difficile",
                        "C. difficile produces toxins A and B which contribute to development of CDAD; CDAD must be considered in all patients who present with diarrhea following antibacterial use; careful medical history is necessary because CDAD has been reported to occur more than 2 months after administration of antibacterial agents",
                        "If CDAD is confirmed, discontinue antibacterials not directed against C. difficile, if possible; manage fluid and electrolyte levels as appropriate, supplement protein intake, monitor antibacterial treatment of C. difficile, and institute surgical evaluation as clinically indicated"
                    ]
                }
            ]
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Increased hepatic transaminase",
            "percent": "11.9"
        },
        {
            "name": "Nausea",
            "percent": "2.8-7.9"
        },
        {
            "name": "Headache",
            "percent": "2.5-5.8"
        },
        {
            "name": "Diarrhea",
            "percent": "1.9-6.2"
        },
        {
            "name": "Pyrexia",
            "percent": "1.7-5.6"
        },
        {
            "name": "Constipation",
            "percent": "1.9-3.9"
        },
        {
            "name": "Insomnia",
            "percent": "1.3-3.5"
        },
        {
            "name": "Vomiting",
            "percent": "1.1-3.3"
        },
        {
            "name": "Hypokalemia",
            "percent": "0.8-3.3"
        },
        {
            "name": "ALT increased",
            "percent": "1.7-1.5"
        },
        {
            "name": "AST increased",
            "percent": "1-1.7"
        },
        {
            "name": "Anemia",
            "percent": "0.4-1.5"
        },
        {
            "name": "Thrombocytosis",
            "percent": "0.4-1.9"
        },
        {
            "name": "Abdominal pain",
            "percent": "0.8-1.2"
        },
        {
            "name": "Anxiety",
            "percent": "0.2-1.9"
        },
        {
            "name": "Dizziness",
            "percent": "0.8-1.1"
        },
        {
            "name": "Hypotension",
            "percent": "0.4-1.7"
        },
        {
            "name": "Atrial fibrillation",
            "percent": "0.2-1.2"
        },
        {
            "name": "Rash",
            "percent": "0.9-1.7"
        },
        {
            "name": "Renal impairment",
            "percent": "8.9"
        },
        {
            "name": "failure",
            "percent": "6.4"
        },
        {
            "name": "Diarrhea",
            "percent": "4.4"
        },
        {
            "name": "Intracranial hemorrhage",
            "percent": "3.3"
        },
        {
            "name": "Vomiting",
            "percent": "2.8"
        },
        {
            "name": "Clostridioides difficile",
            "percent": null
        },
        {
            "name": "associated diarrhea",
            "percent": null
        },
        {
            "name": "Cardiac disorders",
            "percent": null
        },
        {
            "name": "Tachycardia",
            "percent": null
        },
        {
            "name": "angina pectoris",
            "percent": null
        },
        {
            "name": "Gastrointestinal disorders",
            "percent": null
        },
        {
            "name": "Ileus",
            "percent": null
        },
        {
            "name": "gastritis",
            "percent": null
        },
        {
            "name": "abdominal distension",
            "percent": null
        },
        {
            "name": "dyspepsia",
            "percent": null
        },
        {
            "name": "flatulence",
            "percent": null
        },
        {
            "name": "paralytic ileus",
            "percent": null
        },
        {
            "name": "General disorders and administration site conditions",
            "percent": null
        },
        {
            "name": "Infusion site reactions",
            "percent": null
        },
        {
            "name": "Infections and infestations",
            "percent": null
        },
        {
            "name": "Candidiasis candidiasis",
            "percent": null
        },
        {
            "name": "including oropharyngeal and vulvovaginal",
            "percent": null
        },
        {
            "name": "fungal urinary tract infection",
            "percent": null
        },
        {
            "name": "Investigations",
            "percent": null
        },
        {
            "name": "Increased serum gamma",
            "percent": null
        },
        {
            "name": "glutamyl transpeptidase",
            "percent": null
        },
        {
            "name": "GGT",
            "percent": null
        },
        {
            "name": "increased serum alkaline phosphatase",
            "percent": null
        },
        {
            "name": "positive Coombs test",
            "percent": null
        },
        {
            "name": "Metabolism and nutrition disorders",
            "percent": null
        },
        {
            "name": "Hyperglycemia",
            "percent": null
        },
        {
            "name": "hypomagnesemia",
            "percent": null
        },
        {
            "name": "hypophosphatemia",
            "percent": null
        },
        {
            "name": "Nervous system disorders",
            "percent": null
        },
        {
            "name": "Ischemic stroke",
            "percent": null
        },
        {
            "name": "Renal and urinary system",
            "percent": null
        },
        {
            "name": "Renal impairment",
            "percent": null
        },
        {
            "name": "renal failure",
            "percent": null
        },
        {
            "name": "Respiratory",
            "percent": null
        },
        {
            "name": "thoracic",
            "percent": null
        },
        {
            "name": "and mediastinal disorders",
            "percent": null
        },
        {
            "name": "Dyspnea",
            "percent": null
        },
        {
            "name": "Skin and subcutaneous tissue disorders",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Vascular disorders",
            "percent": null
        },
        {
            "name": "Venous thrombosis",
            "percent": null
        }
    ]
}